- Filed
- Nov 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 30, 2025 | 4.81M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 3.92M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 2.9M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 2.35M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 2.25M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $122K |
| Capex | Q3 2025 · Sep 30, 2025 | $10K |
| Capex | Q3 2025 · Sep 30, 2024 | $112K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$5.2M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$3.31M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $9.04M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $6.57M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $3.5M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $1.49M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $1.25M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $242K |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $18.7M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $30.42M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $8M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $10.39M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $23.88M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $25.36M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $4.1M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $4.04M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $40.46M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $53.76M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.02 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$5.06 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$3.92 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$6.82 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.02 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$5.06 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$3.92 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$6.82 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $1.21M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $3.32M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $1.62M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $5.14M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$7.9M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$14.68M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$9.21M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$15.31M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$7.44M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$11.28M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$9.08M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$14.97M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $1.12M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $3.77M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $1.51M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $6.61M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $407K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $445K |